Sartorius AG is a leading international partner of the life sciences research and biopharmaceutical industry. The company operates through two core divisions: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions division, which accounts for approximately 80% of the company's revenue, focuses on single-use solutions, bioreactors, filtration systems, and fluid management technologies that help customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products & Services division contributes the remaining 20% of revenue and provides premium laboratory instruments, such as balances, pipettes, and water purification systems, serving research and quality control laboratories in pharmaceutical companies and academic institutes. Geographically, Sartorius has a global footprint with manufacturing, sales, and R&D sites across Europe, the Americas, and the Asia-Pacific region. The company's competitive position is strengthened by its early and sustained focus on single-use technologies, which offer biopharmaceutical manufacturers greater flexibility, lower capital requirements, and reduced cross-contamination risks compared to traditional stainless-steel equipment.
